s

GpCRC Publications (55)

2023 (4)

  1. Parkman HP, Blackford AL, Murray HB, Yates KP, Grover M, Malik Z, Schey R, Bulat RS, Koch KL, Sarosiek I, Kuo B, Shulman RJ, Chumpitazi BP, Farrugia G, Miriel L, Tonascia J, Hamilton F, Pasricha PJ, McCallum RW, Abell TL. Characteristics and outcomes of patients with gastroparesis using enteral and/or exclusive parenteral nutrition. JPEN J Parenter Enteral Nutr. 2023 Mar 4;. doi: 10.1002/jpen.2493. [Epub ahead of print] PMCID: PMC10164106 (available on 2024-05-01).

  2. Parkman HP, Yates KP, Sarosiek I, Bulat RS, Abell TL, Koch KL, Kuo B, Grover M, Farrugia G, Silver P, Abdullah A, Maurer AH, Malik Z, Miriel LA, Tonascia J, Hamilton F, Pasricha PJ, McCallum RW; NIDDK Gastroparesis Clinical Research Consortium. Buspirone for early satiety and symptoms of gastroparesis: A multi-centre, randomised, placebo-controlled, double-masked trial (BESST). Aliment Pharmacol Ther. 2023 Apr 13. doi: 10.1111/apt.17479. Epub ahead of print. PMCID: PMC10202558 (available on 2024-06-01).

  3. Parkman HP, Wilson LA, Silver P, Maurer AH, Sarosiek I, Bulat RS, Kuo B, Grover M, Farrugia G, Chumpitazi BP, Shulman RJ, Malik Z, Miriel LA, Tonascia J, Hamilton F, Abell TL, Pasricha PJ, McCallum RW, Koch KL; NIDDK Gastroparesis Clinical Research Consortium. Relationships among intragastric meal distribution during gastric emptying scintigraphy, water consumption during water load satiety testing, and symptoms of gastroparesis. Am J Physiol Gastrointest Liver Physiol. 2023 Nov 1;325(5):G407-G417. doi: 10.1152/ajpgi.00065.2023. Epub 2023 Aug 8.  PMC- in process.

  4. Tavares LC, Zheng T, Kwicklis M, Mitchell E, Pandit A, Pullapantula S, Bernard C, Teder-Laving M, Marques FZ, Esko T, Kuo B, Shulman RJ, Chumpitazi BP, Koch KL, Sarosiek I, Abell TL, McCallum RW, Parkman HP, Pasricha PJ, Hamilton FA, Tonascia J, Zawistowski M, Farrugia G, Grover M, D'Amato M. A pilot genome-wide association study meta-analysis of gastroparesis. United European Gastroenterol J. 2023 Oct;11(8):784-796. doi: 10.1002/ueg2.12453. Epub 2023 Sep 8. PMID: 37688361; PMCID: PMC10576603.

 

2022 (6)

 

  1. Koch KL, Van Natta M, Parkman HP, Grover M, Abell TL, McCallum RW, Shaltout HA, Sarosiek I, Farrugia G, Shulman RJ, Tonascia J, Miriel L, Hamilton F, Pasricha PJ; Gastroparesis Clinical Research Consortium. Effect of liquid and solid test meals on symptoms and gastric myoelectrical activity in patients with gastroparesis and functional dyspepsia. Neurogastroenterol Motil. 2022 Apr 11:e14376. doi: 10.1111/nmo.14376. Epub ahead of print. PMCID: PMC9884454

  2. Parkman HP, Sharkey E, McCallum RW, Hasler WL, Koch KL, Sarosiek I, Abell TL, Kuo B, Shulman R, Grover M, Farrugia G, Schey R, Tonascia J, Hamilton F, Pasricha PJ; NIH/NIDDK Gastroparesis Consortium. Constipation in Patients with Symptoms of Gastroparesis: Analysis of Symptoms and Gastrointestinal Transit. Clin Gastroenterol Hepatol. 2022 Mar;20(3):546-558.e5. doi: 10.1016/j.cgh.2020.10.045. Epub 2020 Oct 28. PMC8079462

  3. Parkman HP, Van Natta ML, Makol A, Grover M, McCallum RW,  Malik Z, Koch KL, Sarosiek I, Kuo B, Shulman RJ, Farrugia G, Miriel L, Tonascia J, Hamilton F, Pasricha PJ, Abell TL, for the NIDDK Gastroparesis Clinical Research Consortium. Prevalence and clinical correlates of antinuclear antibody in patients with gastroparesis. Neurogastroenterol Motil. 2022 May;34(5):e14270. doi: 10.1111/nmo.14270. Epub 2021 Oct 1. PMC8971139

  4. Parkman HP, Van Natta ML, Maurer AH, Koch KL, Grover M, Malik Z, Sarosiek I, Abell TL, Bulat RS, Kuo B, Shulman RJ, Farrugia G, Miriel L, Tonascia J, Hamilton FA, Pasricha PJ, McCallum RW. Postprandial Symptoms in Patients with Symptoms of Gastroparesis: Roles of Gastric Emptying and Accommodation. Am J Physiol Gastrointest Liver Physiol. 2022 Jul 1;323(1):G44-G59. doi: 10.1152/ajpgi.00278.2021. Epub 2022 May 3. PMC9236865.

  5. Pasricha PJ, Grover M, Yates KP, Abell TL, Koch KL, McCallum RW, Sarosiek I, Bernard CE, Kuo B, Bulat R, Shulman R, Chumpitazi BP, Tonascia J, Miriel LA, Wilson LA, Van Natta ML, Mitchell E, Hamilton F, Farrugia G, Parkman HP; NIDDK/NIH GpCRC consortium. Progress in gastroparesis - a narrative review of the work of the Gastroparesis Clinical Research Consortium. Clin Gastroenterol Hepatol. 2022 Dec;20(12):2684-2695.e3. doi: 10.1016/j.cgh.2022.05.022. Epub 2022 Jun 7. PMCID: PMC9691520 (available on 2023-12-01)

  6. Sarosiek I, Van Natta M, Parkman HP, Abell T, Koch KL, Kuo B, Shulman RJ, Farrugia G, Grover M, Hamilton FA, Pasricha PJ, Yates KP, Miriel L, Wilson L, Yamada G, Tonascia J, McCallum RW. Effect of Domperidone Therapy on Gastroparesis Symptoms: Results of a Dynamic Cohort Study by NIDDK Gastroparesis Consortium. Clin Gastroenterol Hepatol. 2022 Mar;20(3):e452-e464. doi: 10.1016/j.cgh.2021.05.063. Epub 2021 Jun 2. PMC8636553.

2021 (5)

  1. Parkman HP, Wilson LA, Yates KP, Koch KL, Abell TL, McCallum RW, Sarosiek I, Kuo B, Malik Z, Schey R, Shulman RJ, Grover M, Farrugia G, Miriel L, Tonascia J, Hamilton F, Pasricha PJ; NIDDK/NIH Clinical Gastroparesis Consortium. Factors that contribute to the impairment of quality of life in gastroparesis. Neurogastroenterol Motil. 2021 Jan 25:e14087. doi: 10.1111/nmo.14087. Online ahead of print. PMID: 33493377 PMC8310540  (MS#2015-5) (full text)

  2. Pasricha PJ, Grover M, Yates KP, Abell TL, Bernard CE, Koch KL, McCallum RW, Sarosiek I, Kuo B, Bulat R, Chen J, Shulman R, Lee L, Tonascia J, Miriel LA, Hamilton F, Farrugia G, Parkman HP; NIDDK/NIH GpCRC consortium. Functional dyspepsia and gastroparesis in tertiary care are interchangeable syndromes with common clinical and pathological features. Gastroenterology. 2021 Feb 3:S0016-5085(21)00337-1. doi: 10.1053/j.gastro.2021.01.230. Epub ahead of print. PMID: 33548234. PMCID: PMC8547190 (MS#2015-8) (full text)

  3. Sarosiek I, Van Natta M, Parkman HP, Abell T, Koch KL, Kuo B, Shulman RJ, Farrugia G, Grover M, Hamilton FA, Pasricha PJ, Yates KP, Miriel L, Wilson L, Yamada G, Tonascia J, McCallum RW. Effect of Domperidone Therapy on Gastroparesis Symptoms: Results of a Dynamic Cohort Study by NIDDK Gastroparesis Consortium. Clin Gastroenterol Hepatol. 2021 Jun 2;. doi: 10.1016/j.cgh.2021.05.063. [Epub ahead of print] PMID: 34089855. PMCID: PMC8636553 (available on 2023-03-01) (MS#2016-3) (full text)

  4. Varni JW, Shulman RJ, Self MM, Febo-Rodriguez L, Charron H, Williams K, Nurko S, Chumpitazi BP; Gastroparesis Research Consortium (GpCRC). PedsQL™ Gastroparesis Symptoms Module Domain and Item Development: Qualitative Methods. J Pediatr Gastroenterol Nutr. 2021 Apr 5. doi: 10.1097/MPG.0000000000003146. Epub ahead of print. PMID: 33853112. PMCID: PMC8373654 (MS#2020-4p) (full text)

  5. Parkman HP, Van Natta ML, Makol A, Grover M, McCallum RW,  Malik Z, Koch KL, Sarosiek I, Kuo B, Shulman RJ, Farrugia G, Miriel L, Tonascia J, Hamilton F, Pasricha PJ, Abell TL, for the NIDDK Gastroparesis Clinical Research Consortium. Prevalence and clinical correlates of antinuclear antibody in patients with gastroparesis. Neurogastroenterology & Motility. 2021; 00:e14270. https://doi.org/10.1111/nmo.14270 PMID: 34595805 PMCID: PMC8971139 (full text)

2020 (3)

  1. Nguyen L, Wilson LA, Miriel L, Pasricha PJ, Kuo B, Hasler WL, McCallum RW, Sarosiek I, Koch KL, Snape WJ, Farrugia G, Grover M, Clarke J, Parkman HP, Tonascia J, Hamilton F, Abell TL, for the NIDDK Gastroparesis Clinical Research Consortium (GpCRC). Autonomic function in gastroparesis and chronic unexplained nausea and vomiting: Relationship with etiology, gastric emptying, and symptom severity. Neurogastroenterol Motil. 2020;00:e13810. https://doi.org/10.1111/nmo.13810. PMC7377964

  2. Parkman H, Van Natta M, Yamada G, Grover M, McCallum RW, Sarosiek I, Farrugia G, Koch KL, Abell TL, Kuo B, Miriel L, Tonascia J, Hamilton F, Pasricha PJ. Body weight in patients with idiopathic gastroparesis. Neurogastroenterol Motil. 2020; Sep 15 https://doi.org/10.1111/nmo.13974. PMC8180181

  3. Parkman HP, Sharkey E, McCallum RW, Hasler WL, Koch KL, Sarosiek I, Abell TL, Kuo B, Shulman R, Grover M, Farrugia G, Schey R, Tonascia J, Hamilton F, Pasricha PJ; NIH/NIDDK Gastroparesis Consortium. Constipation in Patients with Symptoms of Gastroparesis: Analysis of Symptoms and Gastrointestinal Transit. Clin Gastroenterol Hepatol. 2020 Oct 28:S1542-3565(20)31503-2. doi: 10.1016/j.cgh.2020.10.045. Epub ahead of print.PMC8079462

 

2019 (8)

  1. Hasler WL, Wilson LA, Nguyen LA, Snape WJ, Abell TL, Koch KL, et al. for Gastroparesis Clinical Research Consortium (GpCRC). Clin Gastroenterol Hepatol. Opioid Use and Potency are Associated with Clinical Features, Quality of Life, and Use of Resources in Patients with Gastroparesis. Clin Gastroenterol Hepatol. 2019;17:1285-1294. PMCID: PMC6633865

  2. Parkman HP, Yamada G, Van Natta ML, Yates K, Hasler WL, Sarosiek I, Grover M, et al. Ethnic, Racial, and Sex Differences in Etiology, Symptoms, Treatment, and Symptom Outcomes of Patients With Gastroparesis. Clin Gastroenterol Hepatol. 2019;17:1489-1499. PMCID: PMC6500483

  3. Parkman HP, Wilson LA, Hasler WL, McCallum RW, Sarosiek I, Koch KL, Abell TL, Schey R, Kuo B, Snape WJ, Nguyen L, Farrugia G, Grover M, Clarke J, Miriel L, Tonascia J, Hamilton F, Pasricha PJ. Abdominal Pain in Patients with Gastroparesis: Associations with Gastroparesis Symptoms, Etiology of Gastroparesis, Gastric Emptying, Somatization, and Quality of Life. Dig Dis Sci. 2019;64:2242-2255. PMCID: PMC6656584

  4. Abell TL, Yamada G, McCallum RW, Van Natta ML, Tonascia J, Parkman HP, et al, for the NIDDK Gastroparesis Clinical Research Consortium (GpCRC). Effectiveness of Gastric Electrical Stimulation in Gastroparesis: Results from a Large Prospectively-Collected Database of National Gastroparesis Registries. Neurogastroenterology and Motility. 2019 Oct 1. PMCID: PMC6863164

  5. Koch KL, Hasler WL, Van Natta ML, Calles-Escandon J, Grover M, Pasricha PJ, et al., for the Gastroparesis Clinical Research Consortium (GpCRC). Satiety Testing in Diabetic Gastroparesis: Effects of Insulin Pump Therapy with Continuous Glucose Monitoring on Upper Gastrointestinal Symptoms and Gastric Myoelectrical Activity. Neurogastroenterology and Motility. 2019 Oct. PMC7382784

  6. Parkman HP, Wilson LA, Koch KL, Hasler WH, Nguyen LA, Abell TL, et al., for the Gastroparesis Clinical Research Consortium (GpCRC). Delayed Gastric Emptying Associates with Diabetic Complications in Diabetic Patients with Symptoms of Gastroparesis. Am J Gastroenterol. 2019 Oct 21. [Epub ahead of print] PMCID:  PMC6832848

  7. Grover M, Dasari S, Bernard C, Chikkamenahalli L, Yates K, Pasricha P, Sarosiek I, McCallum RW, Koch K, Abell T, Kuo B, Shulman R, Gibbons S, McKenzie T, Kellogg T, Kendrick M, Tonascia J, Hamilton F, Parkman H, and Farrugia G. Proteomics in gastroparesis: Unique and overlapping protein signatures in diabetic and idiopathic gastroparesis. Am J Physiol Gastrointest Liver Physiol. 2019 Nov 1;317(5):G716-G726. doi: 10.1152/ajpgi.00115.2019. Epub 2019 Sep 4. PMCID: PMC6879892

  8. Parkman HP, Sharkey EP, Nguyen LA, Yates KP, Abell TL, Hasler WL, Snape W, Clarke J, Schey R, Koch KL, Kuo B, McCallum RW, Sarosiek I, Grover M, Farrugia G, Tonascia J, Pasricha PJ; Frank A. Hamilton for the NIH Gastroparesis Consortium. Marijuana Use in Patients with Symptoms of Gastroparesis: Prevalence, Patient Characteristics, and Perceived Benefit. Dig Dis Sci. 2019 Nov 22. doi: 10.1007/s10620-019-05963-2. [Epub ahead of print] PMC7242137

2018 - (6)

  1. Calles-Escandón J, Koch KL, Hasler WL, Van Natta ML, Pasricha PJ, Tonascia J,, et al., for the NIDDK Gastroparesis Clinical Research Consortium (GpCRC). Glucose sensor-augmented continuous subcutaneous insulin infusion in patients with diabetic gastroparesis: An open-label pilot prospective study. PLoS One. 2018;13(4):e0194759.PMCID: PMC5898706

  2. Grover M, Gibbons SJ, Nair AA, Bernard CE, Zubair AS, Eisenman ST, et al. Transcriptomic signatures reveal immune dysregulation in human diabetic and idiopathic gastroparesis. BMC Medical Genomics. 2018 Aug 7;11(1):62. doi: 10.1186/s12920-018-0379-1.PMCID: PMC6081936

  3. Hasler WL, May KP, Wilson LA, Van Natta M, Parkman HP, Pasricha PJ, et al., for the NIDDK Gastroparesis Clinical Research Consortium (GpCRC). Relating gastric scintigraphy and symptoms to motility capsule transit and pressure findings in suspected gastroparesis. Neurogastroenterol Motil. 2018;e13196. PMCID: PMC6004323

  4. Orthey P, Yu D, Van Natta ML, Ramsey FV, Diaz JR, Bennett PA, et al., for the NIDDK Gastroparesis Clinical Research Consortium (GpCRC). Intragastric Meal Distribution during Gastric Emptying Scintigraphy for Assessment of Fundic Accommodation: Correlation with Symptoms of Gastroparesis. J Nucl Med. 2018;59:691-697. PMCID: PMC5932748

  5. Pasricha PJ, Yates KP, Sarosiek I, McCallum RW, Abell TA, Koch KL, et al., for the NIDDK Gastroparesis Clinical Research Consortium (GpCRC). Aprepitant has Mixed Effects on Nausea and Reduces Other Symptoms in Patients With Gastroparesis and Related Disorders. Gastroenterology. 2018;154:65-76. PMCID: PMC5742047

  6. Siraj ES, Homko C, Wilson LA, May P, Rao, AD, Calles J, et al. Islet cell associated autoantibodies and C-peptide levels in patients with diabetes and gastroparesis. Front. Endocrinol. 2018;9:32. doi: 10.3389/fendo.2018.00032. PMCID: PMC5816742

2017 - (3)

  1. Gibbons SJ, Grover M, Choi KM, Wadhwa A, Zubair A, Wilson LA, et al. Repeat polymorphisms in the Homo sapiens heme oxygenase-1 gene in diabetic and idiopathic gastroparesis. PLoS ONE. 12(11):e0187772. PMCID: PMC5697813

  2. Grover M, Bernard CE, Pasricha PJ, Parkman HP, Gibbons SJ, Tonascia J, et al., for the NIDDK Gastroparesis Clinical Research Consortium (GpCRC). Diabetic and idiopathic gastroparesis is associated with loss of CD206-positive macrophages in the gastric antrum. Neurogastroenterol Motil. 2017;29:e13018. PMCID: PMC5423829  

  3. Parkman HP, Hallinan EK, Hasler WL, Farrugia G, Koch KL, Nguyen L, et al., for the NIDDK Gastroparesis Clinical Research Consortium (GpCRC). Early satiety and postprandial fullness in gastroparesis correlate with gastroparesis severity, gastric emptying, and water load testing. Neurogastroenterol Motil. 2017:29(4):doi:10.1111/nmo.12981. PMCID: PMC5367988

2016 - (2)

  1. Parkman HP, Hallinan EK, Hasler WL, Farrugia G, Koch KL, Calles J, Snape WJ, Abell TL, Sarosiek I, McCallum RW, Nguyen L, Pasricha PJ, Clarke J, Miriel L, Lee L, Tonascia J, Hamilton F; NIDDK Gastroparesis Clinical Research Consortium (GpCRC). Nausea and vomiting in gastroparesis: similarities and differences in idiopathic and diabetic gastroparesis. Neurogastroenterol Motil. 2016;28(12):1902-1914. PMCID: PMC5125878

  2. Koch KL, Hasler WL, Yates KP, Parkman, HP, Pasricha PJ, Calles-Escandon J, Snape WJ, Abell TL, McCallum RW, Nguyen LA, Sarosiek I, Farrugia G, Tonascia J, Lee L, Miriel L, Hamilton F. for the NIDDK Gastroparesis Clinical Research Consortium (GpCRC). Baseline features and differences in 48 week clinical outcomes in patients with gastroparesis and type 1 vs type 2 diabetes. Neurogastroenterol Motil. 2016;28(7):1001-1015.PMCID: PMC5319426

2015 - (3)

  1. Pasricha PJ, Yates KP, Nguyen L, Clarke J, Abell TL, Farrugia G, Hasler WL, Koch KL, Snape WJ, McCallum RW, Sarosiek I, Tonascia J, Miriel LA, Lee L, Hamilton F, Parkman HP. Outcomes and Factors Associated With Reduced Symptoms in Patients with Gastroparesis. Gastroenterology. 2015;149(7):1762-1774.e4. PMCID: PMC4663150

  2. Neshatian L, Gibbons SJ, Farrugia G. Macrophages in diabetic gastroparesis--the missing link?. Neurogastroenterol Motil. 2015;27(1):7-18. PMCID: PMC4409126

  3. Angeli TR, Cheng LK, Du P, Wang TH, Bernard CE, Vannucchi MG, Faussone-Pellegrini MS, Lahr C, Vather R, Windsor JA, Farrugia G, Abell TL, O'Grady G. Loss of Interstitial Cells of Cajal and Patterns of Gastric Dysrhythmia in Patients with Chronic Unexplained Nausea and Vomiting. Gastroenterology; 2015;149:56-66. PMCID: PMC4617790

2014 - (1)

  1. Bernard CE1, Gibbons SJ, Mann IS, Froschauer L, Parkman HP, Harbison S, Abell TL, Snape WJ, Hasler WL, McCallum RW, Sarosiek I, Nguyen LA, Koch KL, Tonascia J, Hamilton FA, Kendrick ML, Shen KR, Pasricha PJ, Farrugia G; NIDDK Gastroparesis Clinical Research Consortium (GpCRC). Association of low numbers of CD206-positive cells with loss of ICC in the gastric body of patients with diabetic gastroparesis. Neurogastroenterol Motil. 2014;26:275-84. PMCID: PMC4149814

2013 - (6)

  1. Iorio, R, Lucchinetti, CF, Lennon, VA, Farrugia, G, Pasricha, PJ, Weinshenker, BG, Pittock, SJ, Intractable Nausea and Vomiting from Autoantibodies Against a Brain Water Channel, Clinical Gastroenterology and Hepatology. 2013;11:240-245. PMCID: PMC3581743

  2. Parkman HP, Van Natta ML, Abell TL, McCallum RW, Sarosiek I, Nguyen L, Snape WJ, Koch KL, Hasler WL, Farrugia G, Lee L, Unalp-Arida A, Tonascia J, Hamilton F, Pasricha PJ. Effect of Nortriptyline on Symptoms of Idiopathic Gastroparesis: The NORIG Randomized Clinical Trial. JAMA. 2013;310(24):2640-2649. PMCID: PMC4099968

  3. Hasler WL, Wilson LA, Parkman HP, Koch KL, Abell TL, Nguyen L, Pasricha PJ, Snape WJ, McCallum RW, Sarosiek I, Farrugia G, Calles J, Lee L, Tonascia J, Unalp-Arida A, Hamilton F. Factors related to abdominal pain in gastroparesis: contrast to patients with predominant nausea and vomiting. Neurogastroenterol Motil. 2013; 25:427-e301. PMCID: PMC3907086

  4. Gibbons SJ, Verhulst PJ, Bharucha A, Farrugia G. Review article: carbon monoxide in gastrointestinal physiology and its potential in therapeutics. Aliment Pharmacol Ther. 2013;38:689-702. PMCID: PMC3788684

  5. Farrugia G, Weinshilboum RM. Challenges in implementing genomic medicine: the Mayo Clinic Center for Individualized Medicine. Clin Pharmacol Ther. 2013 Aug;94(2):204-6. PMCID:PMC3909951.

  6. Parkman HP, Yates K, Hasler WL, Nguyen L, Pasricha PJ, Snape WJ, Farrugia G, Koch KL, Calles J, Abell TL, Sarosiek I, McCallum RW, Lee L, Unalp-Arida A, Tonascia J, Hamilton F. Cholecystectomy and Clinical Presentations of Gastroparesis. Dig Dis Sci. 2013;58:1062-73. PMCID: PMC3891205

2012 - (4)

  1. O'Grady G, Angeli TR, Du P, Lahr C, Lammers WJ, Windsor JA, Abell TL, Farrugia G, Pullan AJ, Cheng LK. Abnormal initiation and conduction of slow-wave activity in gastroparesis, defined by high-resolution electrical mapping. Gastroenterology. 2012 Sep;143(3):589-98. Epub 2012 May 27.PMCID: PMC3429650

  2. Faussone-Pellegrini MS, Grover M, Pasricha PJ, Bernard CE, Lurken MS, Smyrk TC, et al.; the NIDDK Gastroparesis Clinical Research Consortium (GpCRC). Ultrastructural differences between diabetic and idiopathic gastroparesis. Journal of Cellular and Molecular Medicine. 2012; 16: 1573-81. PMCID: PMC3250562 

  3. Grover M, Bernard CE, Pasricha PJ, Lurken MS, Faussone-Pellegrini MS, Smyrk TC, et al.  Clinical-histological associations in gastroparesis:  Results from the Gastroparesis Clinical Research Consortium.  Neurogastroenterology & Motility 2012; 24; 531–e249 (Epub:17 Feb 12); PMCID: PMC3353102. 

  4. Grover M, Bernard CE, Pasricha PJ, Parkman HP, Abell TL, Nguyen LA, Snape W, Shen KR, Sarr M, Swain J, Kendrick M, Gibbons S, Ordog T, Farrugia G. Platelet-derived growth factor receptor α (PDGFRα)-expressing "fibroblast-like cells" in diabetic and idiopathic gastroparesis of humans. Neurogastroenterol Motil. 2012 Sep;24(9):844-52. PMCID: PMC3756591.

2011 - (7)

  1. Parkman HP, Yates K, Hasler WL, Nguyen L, Pasricha PJ, Snape WJ, Farrugia G, Koch KL, Calles J, Abell TL, McCallum RW, Lee L, Unalp-Arida A, Tonascia J, Hamilton F for the NIDDK Gastroparesis Clinical Research Consortium. Similarities and differences between diabetic and idiopathic gastroparesis. Clinical Gastroenterology and Hepatology 2011; 9:1056–1064. PMCID: PMC3499102 

  2. Mazzone A, Bernard CE, Strege PR, Beyder A, Galietta LJ, Pasricha PJ, Rae JL, Parkman HP, Linden DR, Szurszewski JH, Ördög T, Gibbons SJ, Farrugia G. Altered expression of Ano1 variants in human diabetic gastroparesis. J Biol Chem. 2011 Apr 15;286(15):13393-403. PMCID: PMC3075685.

  3. Parkman HP, Yates KP, Hasler WL, Nguyen L, Pasricha PJ, Snape WJ, Farrugia G, Calles J, Koch KL, Abell TL, McCallum RW, Lee L, Unalp-Arida A, Tonascia J, Hamilton F for the NIDDK Gastroparesis Clinical Research Consortium (GpCRC). Dietary intake and nutritional deficiencies in patients with diabetic or idiopathic gastroparesis. Gastroenterology, 2011; 141:486-498. PMCID: PMC3499101 

  4. Hasler WL, Wilson LA, Parkman HP, Abell TL, Koch KL, Pasricha PJ, Snape WJ, Farrugia G, Lee L, Tonascia J, Unalp-Arida A, Hamilton F, and The NIDDK Gastroparesis Clinical Research Consortium (GpCRC). Bloating in gastroparesis: severity, impact and associated factors. Am J Gastroenterol, 2011; 106: 1492-1502. PMCID: PMC3137717

  5. Pasricha PJ, Colvin R, Yates K, Hasler WL, Abell TL, Ünalp-Arida A, Nguyen L, Farrugia G, Koch KL, Parkman HP, Snape WJ, Lee L, Tonascia J, Hamilton F and The NIDDK Gastroparesis Clinical Research Consortium (GpCRC). Clinical characteristics of patients with chronic unexplained nausea and vomiting and normal gastric emptying. Clin Gastroenterol Hepatol, 2011; 9: 567-576 [Epub Mar2011] PMCID: PMC3123425

  6. Grover M, Farrugia G, Lurken MS, Bernard CE, Faussone-Pellegrini MS, Smyrk TC, Parkman HP, Abell TL, Snape WJ, Hasler WL, Unalp-Arida A, Nguyen L, Lee L, Tonascia J, Hamilton FA, Pasricha PJ and The Gastroparesis Clinical Research Consortium (GpCRC). Cellular changes in diabetic and idiopathic gastroparesis. Gastroenterology, 2011; 140: 1575-1585. Epub 2011 Feb 4. PMCID: PMC3081914

  7. Parkman HP, Yates K, Hasler WL, Nguyen L, Pasricha PJ, Snape WJ, Farrugia G, Koch KL, Abell TL, McCallum RW, Lee L, Unalp-Arida A, Tonascia J, F Hamilton. Clinical Features of Idiopathic Gastroparesis Vary with Sex, Body Mass, Symptom Onset, Delay in Gastric Emptying, and Gastroparesis Severity. Gastroenterology, 2011; 140: 101-115.e10. PMCID: PMC3089423

2010 - (2)

  1. Hasler WL, Parkman HP, Wilson LA, Pasricha PJ, Koch KL, Abell TL, Snape WJ, Farrugia G, Lee L, Tonascia J, Unalp-Arida A, Hamilton F: Psychological dysfunction is associated with symptom severity but not disease etiology or degree of gastric retention in patients with gastroparesis. Am J Gastroenterol, 2010; 105: 2357-67. PMCID: PMC3070288 

  2. Kashyap P, Farrugia G. Diabetic gastroparesis: what we have learned and had to unlearn in the past 5 years. Gut. 2010 Dec;59(12):1716-26. PMCID: PMC2996823.
 


  Last updated:  08 November 2023
  ©2007, GpCRC, JHU, Department of Epidemiology,  All Rights Reserved  

www.gpcrc.us